Report Code: A03233 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Antibody Production Market
Request Now !Antibodies, also known as immunoglobulins, are large Y-shaped proteins that are produced by plasma cells, and are used by immune system to neutralize pathogens such as bacteria and viruses. The immune system produces antibodies in response to foreign bodies or antigens entering inside the body. The two major types of antibodies are monoclonal and polyclonal antibodies, which can also be produced by hybridoma- and hybridoma-free techniques.
Increase in adoption of targeted immunotherapy, improved approval rate of therapeutic antibodies by regulatory authorities, and rise in R&D expenditure of pharmaceutical and biotechnology companies drive the growth of the global antibody production market. In addition, increase in incidence of infectious diseases and growth in demand for protein therapeutics fuel the market growth. However, high cost of primary antibodies restrains the market growth. Increase in R&D activities for the development of advanced antibodies and the growth in adoption of targeted immunotherapy are expected to provide opportunities for the market.
The global antibody production market is segmented by process, end user, and region. Based on process, the market is categorized into upstream processing, downstream processing, and filtration. The upstream processing segment is further divided into bioreactors and consumables.
The bioreactors segment is subdivided into large-scale bioreactors and single-use bioreactors, whereas consumables segment is subsegmented into media and buffers & reagents. The market by filtration is classified into filtration systems and filtration consumables & accessories. By end user, the market is classified into pharmaceutical & biotechnology companies, diagnostic laboratories, and research institutes. Geographically, it is analyzed across North America, Europe, Asia Pacific, and LAMEA.
The companies profiled in the report are GeneTex, Inc., Thermo Fisher Scientific, Inc., Eli Lilly and Company, Merck KGaA, Pall Corporation, Sigma-Aldrich Corporation, Eppendorf AG, Cellab GmbH, Abcam PLC, and FiberCell Systems Inc.
Key Benefits
Antibody Production Market Report Highlights
Aspects | Details |
---|---|
By Process |
|
By End User |
|
By Region |
|
Key Market Players | Thermo Fisher Scientific, Inc., Cellab GmbH, Eli Lilly and Company, Pall Corporation, Abcam PLC, FiberCell Systems Inc, Merck KGaA, Sigma-Aldrich Corporation, Eppendorf AG, GeneTex, Inc. |
Start reading.
This Report and over 68,075+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers